Fasenra Pen 30 mg /1 ml

Fasenra Pen 30 mg /1 ml is a medicine authorised by Swissmedic under authorisation number 67581. The authorisation holder is AstraZeneca AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 18 May 2020 and the authorisation is valid without a time limit. ATC code R03DX10 places the medicine in the group Drugs for obstructive airway diseases.

  • Dispensing category B
  • Authorisation number 67581
  • ATC R03DX10
  • Biotechnological medicines
Authorisation data
Authorisation number67581
NameFasenra Pen 30 mg /1 ml
Full nameFasenra Pen 30 mg /1 ml, lnjektionslösung in einem Fertigpen
Authorisation holderAstraZeneca AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeR03DX10
First authorisation18 May 2020
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Fasenra Pen 30 mg /1 ml, lnjektionslösung in einem FertigpenB18 May 2020

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Injektor(en), vorgefüllt/PenR03DX1003.04.5.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Fasenra Pen 30 mg /1 ml authorised in Switzerland?

Yes. Fasenra Pen 30 mg /1 ml is authorised by Swissmedic under authorisation number 67581, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Fasenra Pen 30 mg /1 ml have?

Fasenra Pen 30 mg /1 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Fasenra Pen 30 mg /1 ml?

The authorisation holder is AstraZeneca AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com